---
title: "Oppenheimer maintains Outperform rating on Amrize, $55 price target"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299450941.md"
description: "Oppenheimer maintained an Outperform rating on Amrize with a $55 price target, implying 44% upside from the September 17 close. The firm cites Amrize's advantaged market position in North American construction, particularly in data centers and mega-projects, as key drivers. Solid growth prospects are expected due to capacity enhancements, productivity improvements, strong free cash flow, and a proven M&A strategy, supporting double-digit earnings growth."
datetime: "2026-09-18T12:56:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299450941.md)
  - [en](https://longbridge.com/en/news/299450941.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299450941.md)
generator: "portal-rs"
---

# Oppenheimer maintains Outperform rating on Amrize, $55 price target

Oppenheimer maintained their Outperform rating on Amrize's stock with a price target of $55.00.

The price target implies an upside of 44.0% from the Sep 17 close of $38.19.

**Key takeaways from the analyst note**

**Advantaged Market Position**: Amrize is uniquely positioned to capitalize on the increasing demand for construction in North America, particularly with its ability to service mega-projects and a significant share of data center developments, which are expected to drive substantial growth in the coming years.

**Solid Growth Prospects**: With a focus on capacity enhancements and productivity improvements, Amrize is poised for double-digit earnings growth through the cycle, supported by strong free cash flow generation and a proven M&A strategy that adds further upside potential.

Explore more price target data and ratings for Amrize on the .

**Disclaimer**

Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [AMRZ.US](https://longbridge.com/en/quote/AMRZ.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)

## Related News & Research

- [71,604 Amrize Ltd $AMRZ Shares Sold by Generali Asset Management SPA SGR](https://longbridge.com/en/news/303826753.md)
- [Amrize Ltd (NYSE:AMRZ) Plans Dividend of $0.11](https://longbridge.com/en/news/303641364.md)
- [Amrize forecasts 2026 adjusted EBITDA of $2.95 billion-$3.05 billion](https://longbridge.com/en/news/303454473.md)
- [Amrize Reports Q3 Net Income USD 558 Mln](https://longbridge.com/en/news/303509339.md)
- [Amrize Q3 Revenue Rises 2.2% as Pricing Offsets Lower Volumes](https://longbridge.com/en/news/303647009.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**